Johnson & Johnson Change in Inventories 2010-2025 | JNJ
Johnson & Johnson annual/quarterly change in inventories history and growth rate from 2010 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
- Johnson & Johnson change in inventories for the quarter ending March 31, 2025 was $-0.146B, a 58.05% decline year-over-year.
- Johnson & Johnson change in inventories for the twelve months ending March 31, 2025 was $-3.051B, a 20.94% decline year-over-year.
- Johnson & Johnson annual change in inventories for 2024 was $-1.128B, a 14.74% decline from 2023.
- Johnson & Johnson annual change in inventories for 2023 was $-1.323B, a 47.65% decline from 2022.
- Johnson & Johnson annual change in inventories for 2022 was $-2.527B, a 102.48% increase from 2021.
Johnson & Johnson Annual Change in Inventories (Millions of US $) |
2024 |
$-1,128 |
2023 |
$-1,323 |
2022 |
$-2,527 |
2021 |
$-1,248 |
2020 |
$-265 |
2019 |
$-277 |
2018 |
$-644 |
2017 |
$581 |
2016 |
$-249 |
2015 |
$-449 |
2014 |
$-1,120 |
2013 |
$-622 |
2012 |
$-1 |
2011 |
$-715 |
2010 |
$-196 |
2009 |
$95 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Large Cap Pharmaceutical |
$367.191B |
$88.821B |
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|